Chronic Kidney Disease
Novo Nordisk is suing KBP Biosciences over alleged fraudulent claims about the kidney disease drug ocedurenone.
A team analyzed sotagliflozin's effects on hemoglobin in patients with stage 3-4 CKD and type 2 diabetes.
A study compared the risks of cardiovascular events in hospital settings among patients with CKD with and hyperkalemia.
Eli Lilly ended a phase II trial of volenrelaxin in chronic kidney disease "due to a lack of foreseeable clinical benefit."
Previous studies suggest a link between CKD and sleep disorders, but the nature of the association is unclear.
Using NURTuRE-CKD data, researchers studied kidney outcomes and heterogeneity of risk by primary renal diagnosis.
Monlunabant failed in a study of its use in DKD, but Novo Nordisk had positive news about other kidney treatments in 2024.
Can SZC help with RAASi maximization without resultant hyperkalemia in patients with HFrEF and CKD?
A study assessed the kidney benefits of metabolic surgery compared to GLP-1RA treatment in patients with obesity and CKD.
Does the prevalence of cardiovascular-kidney-metabolic syndrome stages vary by social determinants of health?
The FDA has approved Ozempic (semaglutide) to treat chronic kidney disease (CKD) in adults with type 2 diabetes.
A study examined the clinical relevance of urinary mRNA levels in patients with IgA nephropathy (IgAN).
Advertisement
Advertisement
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.